版本:
中国

BRIEF-Cytori Therapeutics completes follow up monitoring visits in FDA approved late-stage STAR trial

May 23 Cytori Therapeutics Inc-

* Cytori Therapeutics Inc - now completed all 48 week follow up monitoring visits in its U.S. FDA approved phase III star trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐